Adlai Nortye Group Ltd.

ANL chart

Adlai Nortye Group Ltd. news

• Adlai Nortye to present new cancer drug AN4035 data at major oncology symposium in Barcelona

  Pluang · Oct 27, 4:26 PM EDT

• Adlai Nortye Announces Oral Presentation for AN4035 Program Update at the Upcoming 38th EORTC-NCI-AACR Symposium

  Yahoo Finance · Oct 27, 4:05 PM EDT

• Adlai Nortye Announces Oral Presentation for AN4035 Program

  GlobeNewswire · Oct 27, 4:05 PM EDT

• Adlai Nortye director Ji Ping sells $163,274 in ANL stock

  Investing.com · Oct 24, 7:38 PM EDT

• Form 4 Adlai Nortye Ltd ADR: Ping Ji (Director) For: 29 September By Investing.com

  Investing.com South Africa · Oct 24, 6:05 PM EDT

• Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab

  Yahoo Finance · Oct 15, 7:00 AM EDT

• Is Adlai Nortye Ltd. Sponsored ADR (ANL) Stock Outpacing Its Medical Peers This Year?

  Yahoo Finance · Oct 14, 8:40 AM EDT

• Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations

  Yahoo Finance · Sep 30, 7:00 AM EDT

• 4.8x P B? Adlai Nortye Group (ANL) On Its AN4035 Trial Progress

  Yahoo Finance · Sep 15, 1:12 PM EDT

• Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC

  Yahoo Finance · Sep 8, 7:00 AM EDT

• These 2 ‘Monster Growth’ Stocks Aren’t Done Climbing, Say Analysts

  Yahoo Finance · Sep 6, 2:00 PM EDT

• Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress

  Yahoo Finance · Aug 14, 7:00 AM EDT

Adlai Nortye Group Ltd. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-15
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-30
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-30
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-08
• 6-KCURRENT REPORT2026-08-26
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-19
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-14
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-03
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-07-17
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-04-16
• 20-FANNUAL REPORT2026-04-10
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-04-01

About Adlai Nortye Group Ltd.

Ticker

ANL (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Singapore

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1944552

Former names

Adlai Nortye Ltd.

Frequently asked questions